Jing Tao Yang

US Patent:

8009900, Aug 30, 2011

Filed:

Sep 17, 2007

Appl. No.:

11/856208

Inventors:

Adrian Barbu - Plainsboro NJ, US
Yefeng Zheng - Plainsboro NJ, US
Jing Yang - Jersey City NJ, US
Bogdan Georgescu - Plainsboro NJ, US
Dorin Comaniciu - Princeton Junction NJ, US

Assignee:

Siemens Medical Solutions USA, Inc. - Malvern PA

International Classification:

G06K 9/00
G06K 9/62

US Classification:

382154, 382159, 345419

Abstract:

A system and method for detecting an object in a high dimensional image space is disclosed. A three dimensional image of an object is received. A first classifier is trained in the marginal space of the object center location which generates a predetermined number of candidate object center locations. A second classifier is trained to identify potential object center locations and orientations from the predetermined number of candidate object center locations and maintaining a subset of the candidate object center locations. A third classifier is trained to identify potential locations, orientations and scale of the object center from the subset of the candidate object center locations. A single candidate object pose for the object is identified.

US Patent:

20220265822, Aug 25, 2022

Filed:

May 2, 2022

Appl. No.:

17/734541

Inventors:

- Bothell WA, US
Stanford Peng - Seattle WA, US
Jing Yang - Bothell WA, US
Haley Neff-LaFord - Lake Stevens WA, US

International Classification:

A61K 39/395
C07K 16/28
A61M 25/00

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.

US Patent:

20220249662, Aug 11, 2022

Filed:

Apr 25, 2022

Appl. No.:

17/728350

Inventors:

- Bothell WA, US
Stanford Peng - Seattle WA, US
Jing Yang - Bothell WA, US
Haley Neff-LaFord - Lake Stevens WA, US
Thomas John Manley - Seattle WA, US

International Classification:

A61K 39/395
C07K 16/28
A61M 25/00

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.

US Patent:

20220218785, Jul 14, 2022

Filed:

Apr 16, 2020

Appl. No.:

17/603827

Inventors:

- Seattle WA, US
Jing YANG - Seattle WA, US
Stanford PENG - Seattle WA, US
Jan HILLSON - Seattle WA, US

Assignee:

Alpine Immune Sciences, Inc. - Seattle WA

International Classification:

A61K 38/13
A61K 38/17
A61P 29/00
A61P 31/12
A61P 37/06

Abstract:

Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

US Patent:

20220177587, Jun 9, 2022

Filed:

Sep 19, 2019

Appl. No.:

17/275646

Inventors:

- Seattle WA, US
Mark F. MAURER - Seattle WA, US
Stanford L. PENG - Seattle WA, US
Jing YANG - Seattle WA, US
Kristine M. SWIDEREK - Seattle WA, US

Assignee:

Alpine Immune Sciences, Inc. - Seattle WA

International Classification:

C07K 16/28
A61K 31/282
C07K 14/705
C12N 15/62
A61P 35/00
A61K 45/06

Abstract:

Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of oncological conditions. Compositions and methods for making and using such proteins are provided.

US Patent:

20200405609, Dec 31, 2020

Filed:

Jun 26, 2019

Appl. No.:

16/452982

Inventors:

- Skillman NJ, US
Derrick Chua - Plainsboro NJ, US
Marisa DeVita Dufort - Hillsborough NJ, US
Allison Keene Rush - Yardley PA, US
Jing Yang - Princeton NJ, US

International Classification:

A61K 8/64
A61K 8/365
A61Q 19/08

Abstract:

The present invention provides topical compositions comprising a combination of an N-acyl dipeptide derivative and glycolic acid. The compositions provide enhanced penetration of the N-acyl dipeptide derivative into the skin.

US Patent:

20170333556, Nov 23, 2017

Filed:

Oct 29, 2015

Appl. No.:

15/522614

Inventors:

- Bothell WA, US
Stanford Peng - Seattle WA, US
Jing Yang - Bothell WA, US
Haley Neff-LaFord - Lake Stevens WA, US

Assignee:

SEATTLE GENETICS, INC. - Bothell WA

International Classification:

A61K 39/395
C07K 16/28
A61K 39/00

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.

US Patent:

20170137528, May 18, 2017

Filed:

Jan 20, 2017

Appl. No.:

15/411741

Inventors:

- Bothell WA, US
Stanford Peng - Seattle WA, US
Jing Yang - Bothell WA, US
Haley Neff-LaFord - Lake Stevens WA, US
Thomas John Manley - Seattle WA, US

Assignee:

SEATTLE GENETICS, INC. - Bothell WA

International Classification:

C07K 16/28
A61K 39/395

Abstract:

This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.